| Helia Group Limited (HLI) ORDINARY FULLY PAID |
Financials |
$1,530 |
Governance review and revised Securities Trading Policy
|
3 Nov 2025 9:17AM |
$5.390 |
$5.615 |
risen by
4.17%
|
|
| Loyal Metals Ltd (LLM) ORDINARY FULLY PAID |
Materials |
$49 |
Proposed issue of securities - LLM
|
3 Nov 2025 9:17AM |
$0.375 |
$0.325 |
fallen by
13.33%
|
|
| Loyal Metals Ltd (LLM) ORDINARY FULLY PAID |
Materials |
$49 |
Loyal Raises $3.5M in Strongly Supported Targeted Placement
|
3 Nov 2025 9:16AM |
$0.375 |
$0.325 |
fallen by
13.33%
|
|
LLM - Price-sensitive ASX Announcement
Full Release
Key Points
- Loyal Metals raised $3.5 million via a targeted placement.
- Strong support from existing shareholders and new investors.
- Funds to accelerate exploration at Highway Reward Copper-Gold Mine.
- Use of AI-driven targeting and next-generation exploration tech.
- Total available funding is $8.2 million for exploration activities.
- Placement involved 10,294,118 new shares at $0.34 per share.
- Canaccord Genuity acted as lead manager for the placement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,934 |
Weekly Estimated NTA as at 31 October 2025
|
3 Nov 2025 9:16AM |
$7.450 |
$7.130 |
fallen by
4.30%
|
|
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,166 |
Update - Notification of buy-back - WHC
|
3 Nov 2025 9:15AM |
$7.200 |
$7.425 |
risen by
3.13%
|
|
| De.mem Limited (DEM) ORDINARY FULLY PAID |
Utilities |
$36 |
Acquisition of Core Chemicals Completed
|
3 Nov 2025 9:15AM |
$0.110 |
$0.110 |
fallen by
0%
|
|
DEM - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition of Core Chemicals completed effective 31 October 2025.
- Core Chemicals supplies specialty chemicals to the Western Australian gold mining sector.
- Total consideration for the acquisition is approximately $3 million.
- De.mem gains increased exposure to the gold mining sector.
- Significant revenue synergies expected through new client acquisition and cross-selling.
- Core Chemicals generated $4 million in revenue for 12 months ending 30 June 2025.
- Pro-forma adjusted EBITDA of $1.6 million anticipated for the 12 months to 30 June 2025.
- Strong pro-forma cash balance reported as $3.7 million as of 30 September 2025.
- Strategic geographic expansion opportunities into Eastern Australia and Pacific region.
- Potential for significant cost synergies and revenue growth in the gold sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| West Cobar Metals Limited (WC1) ORDINARY FULLY PAID |
Materials |
$7 |
Proposed issue of securities - WC1
|
3 Nov 2025 9:13AM |
$0.026 |
$0.019 |
fallen by
26.92%
|
|
| West Cobar Metals Limited (WC1) ORDINARY FULLY PAID |
Materials |
$7 |
Proposed issue of securities - WC1
|
3 Nov 2025 9:13AM |
$0.026 |
$0.019 |
fallen by
26.92%
|
|
| West Cobar Metals Limited (WC1) ORDINARY FULLY PAID |
Materials |
$7 |
Successful Placement
|
3 Nov 2025 9:12AM |
$0.026 |
$0.019 |
fallen by
26.92%
|
|
WC1 - Price-sensitive ASX Announcement
Full Release
Key Points
- West Cobar Metals Limited announced a successful placement of shares.
- The company received commitments from investors for 68,181,818 shares at $0.022 each.
- The placement aims to raise gross proceeds of $1,500,000.
- The issue price was at a 22% discount to the last closing price.
- Funds will support projects like the Salazar Critical Minerals Project and Bulla Park Project.
- Completion of the placement is expected by 10 November 2025.
- Xcel Capital Pty Ltd is the lead manager for the placement.
- Managing Director Matt Szwedzicki expressed optimism about the company’s critical minerals projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$277 |
Remplir Launches in Hong Kong with First Surgical Case
|
3 Nov 2025 9:12AM |
$1.165 |
$1.020 |
fallen by
12.45%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful completion of first Remplirâ„¢ surgical case in Hong Kong.
- Launch at Hong Kong Orthopaedic Association's 45th Annual Congress.
- Appointment of MontsMed as exclusive distributor for Hong Kong.
- Hong Kong serves as a strategic entry point to Greater Bay Area.
- Initial surgeries in Singapore and USA; sales expected in Canada and Thailand.
- Orthocell well-funded with A$50 million and aims for revenue growth in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Panther Metals Ltd (PNT) ORDINARY FULLY PAID |
Materials |
$2 |
Non-Renounceable Rights Issue to Raise $817k
|
3 Nov 2025 9:12AM |
$0.011 |
$0.008 |
fallen by
23.81%
|
|
PNT - Price-sensitive ASX Announcement
Full Release
Key Points
- $817k non-renounceable rights issue
- 20% discount to the last closing price
- Funds for Laverton Gold Project exploration
- Shortfall facility available for additional shares
- Directors committed to $105,000
- Offer open in Australia, New Zealand, and UK
- Closing date is 21 November 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$97 |
Update - Notification of buy-back - ARA
|
3 Nov 2025 9:11AM |
$0.500 |
$0.500 |
fallen by
0%
|
|
| Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$273 |
RGP Advances Following Key Permitting Milestone
|
3 Nov 2025 9:11AM |
$0.455 |
$0.445 |
fallen by
2.20%
|
|
MM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Ravensthorpe Gold Project (RGP) has advanced to the final stage of assessment under the Environment Protection and Biodiversity Conservation Act 1999 (EPBC Act).
- A determination on the proposed action is expected during December 2025, subject to no requests for additional information.
- Approval under the EPBC Act is crucial for Medallion Metals' sulphide production strategy.
- The project is being assessed on Preliminary Documentation with no public comments received during the 20-business day comment period.
- Further secondary approvals will be needed under State (WA) legislation.
- This announcement is authorized for release by the Board of Medallion Metals Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Retail Food Group Limited (RFG) ORDINARY FULLY PAID |
Consumer Discretionary |
$101 |
Change in substantial holding
|
3 Nov 2025 9:10AM |
$1.470 |
$1.600 |
risen by
8.84%
|
|
| Alma Metals Limited (ALM) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$13 |
Briggs Copper Project - Expansion of Drilling Program
|
3 Nov 2025 9:09AM |
$0.008 |
$0.007 |
fallen by
12.50%
|
|
ALM - Price-sensitive ASX Announcement
Full Release
Key Points
- Alma Metals Limited reached a 51% joint venture interest in Briggs Copper Project in August 2024.
- Alma aims for 70% JV interest by spending $10 million by June 2031.
- Exploration involves drilling into granodiorite porphyry stocks with copper and molybdenum.
- Copper deposition is multi-stage, linked to different alterations and intrusions.
- Further drilling is planned to explore potential extensions.
- The geological settings indicate promising mineralization and exploration potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$213 |
Appointment of Joint Company Secretary
|
3 Nov 2025 9:09AM |
$0.530 |
$0.500 |
fallen by
5.66%
|
|
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,372 |
BKI 31 October 2025 Weekly NTA
|
3 Nov 2025 9:09AM |
$1.800 |
$1.700 |
fallen by
5.56%
|
|
| Cash Converters International (CCV) ORDINARY FULLY PAID |
Financials |
$213 |
Notice under section 708A(5)(e) of the Corporations Act
|
3 Nov 2025 9:09AM |
$0.315 |
$0.300 |
fallen by
4.76%
|
|
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,353 |
Net Tangible Asset Backing - 31 October 2025
|
3 Nov 2025 9:09AM |
$2.720 |
$2.820 |
risen by
3.68%
|
|
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$242 |
FDA Approves DurAVR THV Global Pivotal Trial
|
3 Nov 2025 9:08AM |
$7.070 |
$6.300 |
fallen by
10.89%
|
|
AVR - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA approved the PARADIGM Trial for DurAVR® THV.
- Trial aims to evaluate DurAVR® THV for severe calcific aortic stenosis.
- PARADIGM Trial involves 1000 patients across the US, Europe, and Canada.
- The trial compares DurAVR® THV with existing TAVR devices.
- It seeks to support FDA Premarket Approval and CE Mark.
- DurAVR® THV is a biomimetic valve for aortic stenosis.
- Anteris uses ADAPT® tissue technology in DurAVR® THV.
- The trial is a critical step in Anteris' global expansion strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orcoda Limited (ODA) ORDINARY FULLY PAID |
Information Technology |
$13 |
Change of Director's Interest Notice - Geoff Jamieson
|
3 Nov 2025 9:08AM |
$0.071 |
$0.067 |
fallen by
5.63%
|
|
| FireFly Metals Ltd (FFM) ORDINARY FULLY PAID |
Materials |
$1,239 |
Director Appointment/Resignation
|
3 Nov 2025 9:07AM |
$1.900 |
$1.815 |
fallen by
4.47%
|
|
| L1 Group Limited (L1G) ORDINARY FULLY PAID |
Financials |
$2,579 |
Appendix 3X - Julian Russell
|
3 Nov 2025 9:07AM |
$1.130 |
$1.005 |
fallen by
11.06%
|
|
| White Cliff Minerals Limited (WCN) ORDINARY FULLY PAID |
Materials |
$44 |
Strategic acquisition of Bornite Lake prospect at Rae
|
3 Nov 2025 9:07AM |
$0.020 |
$0.018 |
fallen by
10%
|
|
WCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Strategic acquisition of the Bornite Lake prospect at Rae.
- Consolidation of holdings along the Herb Dixon fault.
- Evidence of high-grade chalcocite-bornite mineralization.
- Historical copper and silver content reported.
- Plans to explore fault intersections for further mineralization.
- Acquisition enables a unified, province-scale strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$78 |
Update - Notification of buy-back - ATG
|
3 Nov 2025 9:06AM |
$0.320 |
$0.265 |
fallen by
17.19%
|
|